Additionally, it is associated with longer disease-free survival in stage II colon cancer [57] MiRNA31 promotes colon cancer cell proliferation, invasion and migration through the suppression of SATB2; and the expression of miRNA31 in clinical tumours is associated with the more aggressive and poor prognostic phenotypes of CRC [58]. This evidence concerns the gene SATB2 and malignant colon neoplasm.